BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 19551554)

  • 41. Pet ownership: its effect on allergy and respiratory symptoms.
    Bener A; Mobayed H; Sattar HA; Al-Mohammed AA; Ibrahimi AS; Sabbah A
    Eur Ann Allergy Clin Immunol; 2004 Oct; 36(8):306-10. PubMed ID: 15623245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hoarseness: is it really laryngopharyngeal reflux?
    Cohen SM; Garrett CG
    Laryngoscope; 2008 Feb; 118(2):363-6. PubMed ID: 18025948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Do clinical symptoms and laryngoscopic findings of laryngo-pharyngeal reflux correlate?].
    Gugatschka M; Schoekler B; Kiesler K; Friedrich G
    Laryngorhinootologie; 2008 Dec; 87(12):867-9. PubMed ID: 18629756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Voice disorders in the elderly.
    Gregory ND; Chandran S; Lurie D; Sataloff RT
    J Voice; 2012 Mar; 26(2):254-8. PubMed ID: 21530163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Reflux Symptom Index and Symptom Overlap in Dysphonic Patients.
    Kavookjian H; Irwin T; Garnett JD; Kraft S
    Laryngoscope; 2020 Nov; 130(11):2631-2636. PubMed ID: 32027383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Laryngopharyngeal Reflux (LPR) in patients with persistent hoarseness].
    Dymek A; Dymek L; Starczewska-Dymek L; Bożek A; Dymek T; Nowak K
    Otolaryngol Pol; 2012; 66(1):33-8. PubMed ID: 22381012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study.
    Lechien JR; Finck C; Huet K; Khalife M; Fourneau AF; Delvaux V; Piccaluga M; Harmegnies B; Saussez S
    Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3687-3696. PubMed ID: 28717979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors confusing the diagnosis of laryngopharyngeal reflux: the role of allergic rhinitis and inter-rater variability of laryngeal findings.
    Eren E; Arslanoğlu S; Aktaş A; Kopar A; Ciğer E; Önal K; Katılmiş H
    Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):743-7. PubMed ID: 23999594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fundoplication for laryngopharyngeal reflux disease.
    Westcott CJ; Hopkins MB; Bach K; Postma GN; Belafsky PC; Koufman JA
    J Am Coll Surg; 2004 Jul; 199(1):23-30. PubMed ID: 15217625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between anxiety, type A personality, and treatment outcome of dysphonia due to benign causes.
    Ng JH; Lo S; Lim F; Goh S; Kanagalingam J
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):96-102. PubMed ID: 23112274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using RSI and RFS scores to differentiate between reflux-related and other causes of chronic laryngitis.
    Eckley CA; Tangerina R
    Braz J Otorhinolaryngol; 2023; 89(1):54-59. PubMed ID: 34840124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of life in laryngopharyngeal reflux patients.
    Siupsinskiene N; Adamonis K; Toohill RJ
    Laryngoscope; 2007 Mar; 117(3):480-4. PubMed ID: 17334308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
    Bilgen C; Ogüt F; Kesimli-Dinç H; Kirazli T; Bor S
    J Laryngol Otol; 2003 May; 117(5):386-90. PubMed ID: 12803789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidimentional assessment of voice quality in patients with laryngopharyngeal reflux disease.
    Kosztyła-Hojna B; Rogowski M; Duchnowska E; Zdrojkowski M; Łobaczuk-Sitnik A
    Otolaryngol Pol; 2023 Aug; 78(1):20-30. PubMed ID: 38332705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update).
    Stachler RJ; Francis DO; Schwartz SR; Damask CC; Digoy GP; Krouse HJ; McCoy SJ; Ouellette DR; Patel RR; Reavis CCW; Smith LJ; Smith M; Strode SW; Woo P; Nnacheta LC
    Otolaryngol Head Neck Surg; 2018 Mar; 158(1_suppl):S1-S42. PubMed ID: 29494321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
    Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
    J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laryngeal disorders in patients with gastroesophageal reflux disease.
    Farrokhi F; Vaezi MF
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):181-7. PubMed ID: 17557046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Voice problems among laryngopharyngeal reflux patients diagnosed with oropharyngeal pH monitoring.
    Mesallam TA; Malki KH; Farahat M; Bukhari M; Alharethy S
    Folia Phoniatr Logop; 2013; 65(6):280-7. PubMed ID: 24861352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors and demographics in patients with spasmodic dysphonia.
    Schweinfurth JM; Billante M; Courey MS
    Laryngoscope; 2002 Feb; 112(2):220-3. PubMed ID: 11889373
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of PH Monitoring in Laryngopharyngeal Reflux Patients with Voice Disorders.
    Maldhure S; Chandrasekharan R; Dutta AK; Chacko A; Kurien M
    Iran J Otorhinolaryngol; 2016 Nov; 28(89):377-383. PubMed ID: 28008387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.